{"id":"https://openalex.org/W4409688967","doi":"https://doi.org/10.1158/1538-7445.am2025-3275","title":"Abstract 3275: Reprogramming of MDSCs by ST316, a clinical peptide antagonist of b-Catenin/BCL9, enhances anti-tumor immuno- and chemotherapy","display_name":"Abstract 3275: Reprogramming of MDSCs by ST316, a clinical peptide antagonist of b-Catenin/BCL9, enhances anti-tumor immuno- and chemotherapy","publication_year":2025,"publication_date":"2025-04-21","ids":{"openalex":"https://openalex.org/W4409688967","doi":"https://doi.org/10.1158/1538-7445.am2025-3275"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2025-3275","doi":"https://doi.org/10.1158/1538-7445.am2025-3275","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2025-3275","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5019291778","display_name":"Claudio Scuoppo","orcid":"https://orcid.org/0000-0003-4615-0883","observed_orcids":["https://orcid.org/0000-0003-4615-0883"]},"institutions":[{"id":"https://openalex.org/I4405263104","display_name":"Sapience Therapeutics","ror":"https://ror.org/02mg3ab08","country_code":"US","type":"company","lineage":["https://openalex.org/I4405263104"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Claudio Scuoppo","raw_affiliation_strings":["Sapience Therapeutics, Inc., Tarrytown, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sapience Therapeutics, Inc., Tarrytown, NY","institution_ids":["https://openalex.org/I4405263104"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113150264","display_name":"Julia Diehl","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405263104","display_name":"Sapience Therapeutics","ror":"https://ror.org/02mg3ab08","country_code":"US","type":"company","lineage":["https://openalex.org/I4405263104"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Julia Diehl","raw_affiliation_strings":["Sapience Therapeutics, Inc., Tarrytown, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sapience Therapeutics, Inc., Tarrytown, NY","institution_ids":["https://openalex.org/I4405263104"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029317866","display_name":"Ricardo Ramirez","orcid":"https://orcid.org/0000-0003-3453-6164","observed_orcids":["https://orcid.org/0000-0003-3453-6164"]},"institutions":[{"id":"https://openalex.org/I4405263104","display_name":"Sapience Therapeutics","ror":"https://ror.org/02mg3ab08","country_code":"US","type":"company","lineage":["https://openalex.org/I4405263104"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ricardo Ramirez","raw_affiliation_strings":["Sapience Therapeutics, Inc., Tarrytown, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sapience Therapeutics, Inc., Tarrytown, NY","institution_ids":["https://openalex.org/I4405263104"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089113472","display_name":"Barry J. Kappel","orcid":"https://orcid.org/0000-0002-0344-8826","observed_orcids":["https://orcid.org/0000-0002-0344-8826"]},"institutions":[{"id":"https://openalex.org/I4405263104","display_name":"Sapience Therapeutics","ror":"https://ror.org/02mg3ab08","country_code":"US","type":"company","lineage":["https://openalex.org/I4405263104"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Barry J. Kappel","raw_affiliation_strings":["Sapience Therapeutics, Inc., Tarrytown, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sapience Therapeutics, Inc., Tarrytown, NY","institution_ids":["https://openalex.org/I4405263104"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060798513","display_name":"Abi Vainstein\u2010Haras","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405263104","display_name":"Sapience Therapeutics","ror":"https://ror.org/02mg3ab08","country_code":"US","type":"company","lineage":["https://openalex.org/I4405263104"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Abi Vainstein-Haras","raw_affiliation_strings":["Sapience Therapeutics, Inc., Tarrytown, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sapience Therapeutics, Inc., Tarrytown, NY","institution_ids":["https://openalex.org/I4405263104"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5048924826","display_name":"Jimmy A. Rotolo","orcid":"https://orcid.org/0000-0003-4195-6167","observed_orcids":["https://orcid.org/0000-0003-4195-6167"]},"institutions":[{"id":"https://openalex.org/I4405263104","display_name":"Sapience Therapeutics","ror":"https://ror.org/02mg3ab08","country_code":"US","type":"company","lineage":["https://openalex.org/I4405263104"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jim A. Rotolo","raw_affiliation_strings":["Sapience Therapeutics, Inc., Tarrytown, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sapience Therapeutics, Inc., Tarrytown, NY","institution_ids":["https://openalex.org/I4405263104"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4405263104"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"85","issue":"8_Supplement_1","first_page":"3275","last_page":"3275"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11313","display_name":"Immune cells in cancer","score":0.9740999937057495,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11313","display_name":"Immune cells in cancer","score":0.9740999937057495,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.012900000438094139,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.008500000461935997,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/myeloid-derived-suppressor-cells","display_name":"myeloid-derived suppressor cells","score":0.9330000281333923},{"id":"https://openalex.org/keywords/bcl9","display_name":"BCL9","score":0.7269999980926514},{"id":"https://openalex.org/keywords/beta-catenin","display_name":"\u03b2-catenin","score":0.7950000166893005},{"id":"https://openalex.org/keywords/wnt-beta-catenin-signaling","display_name":"Wnt/\u03b2-catenin signaling","score":0.9679999947547913},{"id":"https://openalex.org/keywords/colorectal-cancer","display_name":"colorectal cancer","score":0.9679999947547913},{"id":"https://openalex.org/keywords/immunosuppression","display_name":"immunosuppression","score":0.7889999747276306},{"id":"https://openalex.org/keywords/anti-pd-1-therapy","display_name":"anti-PD-1 therapy","score":0.8769999742507935},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.7059999704360962},{"id":"https://openalex.org/keywords/t-cell-suppression","display_name":"T cell suppression","score":0.8119999766349792},{"id":"https://openalex.org/keywords/peptide-antagonists","display_name":"peptide antagonists","score":0.6000000238418579},{"id":"https://openalex.org/keywords/tumor-immune-microenvironment","display_name":"tumor immune microenvironment","score":0.6809999942779541},{"id":"https://openalex.org/keywords/immunotherapy-resistance","display_name":"immunotherapy resistance","score":0.5230000019073486},{"id":"https://openalex.org/keywords/bcl9l","display_name":"BCL9L","score":0.5339999794960022}],"concepts":[{"id":"https://openalex.org/C77255625","wikidata":"https://www.wikidata.org/wiki/Q402093","display_name":"Reprogramming","level":3,"score":0.7172033786773682},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.5926896333694458},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.49682024121284485},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.39188629388809204},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.35989630222320557},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.2922908067703247},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.1898394525051117},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1805526614189148},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.12865614891052246},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0967627763748169}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2025-3275","doi":"https://doi.org/10.1158/1538-7445.am2025-3275","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2025-3275","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9922999739646912}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2899084033","https://openalex.org/W2748952813","https://openalex.org/W3031052312","https://openalex.org/W4389568370","https://openalex.org/W3032375762","https://openalex.org/W1995515455","https://openalex.org/W2080531066","https://openalex.org/W3108674512","https://openalex.org/W1506200166","https://openalex.org/W1489783725"],"abstract_inverted_index":{"Abstract":[0],"Myeloid-derived":[1],"suppressor":[2],"cells":[3,11],"(MDSCs)":[4],"are":[5,20,189],"a":[6,62,81,102,122,262,333],"diverse":[7],"group":[8],"of":[9,43,49,85,137,154,176,205,228,250,279,329,337,347],"immune":[10],"that":[12,66,128,182,198,273,287,307],"play":[13],"critical":[14],"roles":[15,74],"in":[16,26,38,70,75,101,107,114,121,133,144,158,192,217,248,268,282,304],"mediating":[17],"immune-suppression.":[18],"They":[19],"often":[21],"associated":[22],"with":[23,109,116,254],"poor":[24],"responses":[25,216],"various":[27],"cancer":[28,112],"types":[29],"and":[30,90,94,140,161,171,184,231,243,271,302,342],"represent":[31],"an":[32,295],"attractive":[33],"target":[34],"for":[35,234,265,351],"immunotherapy.":[36],"Challenges":[37],"defining":[39],"the":[40,47,86,134,152,155,163,203,225,277,290,348],"genetic":[41],"dependencies":[42],"MDSCs":[44,177,281,330],"have":[45],"hindered":[46],"development":[48],"effective":[50,296],"therapeutic":[51],"strategies":[52],"aimed":[53],"at":[54],"targeting":[55,289],"them.":[56],"The":[57],"Wnt/\u03b2-catenin":[58,266],"signaling":[59,267],"pathway":[60,157,187],"is":[61,80,98],"key":[63],"oncogenic":[64],"driver":[65],"has":[67],"been":[68],"implicated":[69],"immune-exclusion,":[71],"although":[72],"additional":[73],"immune-suppression":[76],"remain":[77],"unclear.":[78],"ST316":[79,97,129,167,201,222,255,274],"clinical-stage":[82],"peptide":[83,335],"antagonist":[84,336],"interaction":[87,292],"between":[88],"\u03b2-catenin":[89,183],"its":[91],"co-activators,":[92],"BCL9":[93],"BCL9L.":[95],"Currently,":[96],"being":[99],"evaluated":[100],"Phase":[103,123],"2":[104],"study":[105,127],"(NCT05848739)":[106],"patients":[108,139],"advanced":[110,235],"colorectal":[111],"(CRC)":[113],"combination":[115,220,253],"standard-of-care":[117,232],"agents.":[118],"We":[119],"demonstrated":[120],"1":[124,358],"dose":[125],"escalation":[126],"suppresses":[130],"MDSC":[131,159,169,269],"expansion":[132,249],"peripheral":[135],"blood":[136],"treated":[138],"corroborated":[141],"these":[142,193],"findings":[143,196],"non-clinical":[145],"CRC":[146,236],"murine":[147],"models.":[148],"Here,":[149],"we":[150],"characterize":[151],"role":[153,264],"Wnt/\u03b2-catenin/BCL9":[156],"programming":[160],"investigate":[162],"mechanism":[164],"by":[165,331],"which":[166],"reduces":[168,202],"expression":[170,204],"immuno-suppressive":[172],"activity.":[173],"Transcriptional":[174],"profiling":[175],"from":[178],"tumor-bearing":[179],"mice":[180],"indicates":[181],"other":[185],"Wnt":[186],"components":[188],"highly":[190],"expressed":[191],"cells.":[194],"Our":[195,259],"indicate":[197],"exposure":[199],"to":[200,209,298,310],"receptor":[206],"systems":[207],"linked":[208],"MDSC-mediated":[210],"T-cell":[211,215],"suppression,":[212],"thereby":[213],"activating":[214],"vivo.":[218,283],"In":[219],"studies,":[221],"significantly":[223],"enhances":[224,339],"anti-tumor":[226,340],"efficacy":[227],"anti-PD-1":[229,242],"immunotherapy":[230,303],"chemotherapies":[233],"such":[237],"as":[238],"FOLFIRI.":[239],"Moreover,":[240],"while":[241],"FOLFIRI":[244],"alone":[245],"each":[246],"resulted":[247],"immunosuppressive":[251],"MDSCs,":[252],"prevented":[256],"this":[257],"expansion.":[258],"results":[260],"reveal":[261],"novel":[263],"biology":[270],"demonstrate":[272],"can":[275],"suppress":[276],"increase":[278],"therapy-driven":[280],"These":[284],"data":[285],"suggest":[286],"therapeutically":[288],"BCL9/\u03b2-catenin":[291],"may":[293],"be":[294],"strategy":[297],"enhance":[299],"both":[300],"chemotherapy":[301,343],"Wnt-driven":[305],"tumors":[306],"respond":[308],"poorly":[309],"monotherapy.":[311],"Citation":[312],"Format:":[313],"Claudio":[314],"Scuoppo,":[315],"Julia":[316],"Diehl,":[317],"Ricardo":[318],"Ramirez,":[319],"Barry":[320],"J.":[321],"Kappel,":[322],"Abi":[323],"Vainstein-Haras,":[324],"Jim":[325],"A.":[326],"Rotolo.":[327],"Reprogramming":[328],"ST316,":[332],"clinical":[334],"b-Catenin/BCL9,":[338],"immuno-":[341],"[abstract].":[344],"In:":[345],"Proceedings":[346],"American":[349],"Association":[350],"Cancer":[352,369],"Research":[353],"Annual":[354],"Meeting":[355],"2025;":[356],"Part":[357],"(Regular":[359],"Abstracts);":[360],"2025":[361],"Apr":[362],"25-30;":[363],"Chicago,":[364],"IL.":[365],"Philadelphia":[366],"(PA):":[367],"AACR;":[368],"Res":[370],"2025;85(8_Suppl_1):Abstract":[371],"nr":[372],"3275.":[373]},"counts_by_year":[],"updated_date":"2026-09-22T17:25:34.749102","created_date":"2025-10-10T00:00:00"}